Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrea Ferrario

Showing results (41-50 of 62) with videos related to

Pageof 7
Sort By:
Critical Care (London, England)|January 8, 2026
Longitudinal trajectories of functional outcome following aneurysmal subarachnoid hemorrhage: a retrospective studyIgnazio de Trizio, Andrea Ferrario, Stefan Yu Bögli, et al.
Journal of Biomedical Informatics|January 31, 2023
An interpretable machine learning approach to multimodal stress detection in a simulated office environmentMara Naegelin, Raphael P Weibel, Jasmine I Kerr, et al.
Psychoneuroendocrinology|September 22, 2020
The effects of acute work stress and appraisal on psychobiological stress responses in a group office environmentJasmine I Kerr, Mara Naegelin, Raphael P Weibel, et al.
Iscience|December 25, 2025
Beyond locomotion: How specialized motor patterns enable a vertebrate to struggle free from captureSaeed Farjami, Andrey Palyanov, Hong-Yan Zhang, et al.
Annals of Hematology|September 18, 2010
Phase II fludarabine and cyclophosphamide for the treatment of indolent B cell non-follicular lymphomas: final results of the LL02 trial of the Gruppo Italiano per lo Studio dei Linfomi (GISL)Andrea Ferrario, Francesco Merli, Stefano Luminari, et al.
Leukemia & Lymphoma|December 3, 2016
A new acute myeloid leukemia case with STAT5B-RARA gene fusion due to 17q21.2 interstitial deletionChiara Pessina, Claudia Basilico, Angelo Genoni, et al.
Hematological Oncology|February 28, 2009
CD26 expression in mature B-cell neoplasia: its possible role as a new prognostic marker in B-CLLLilla Cro, Fortunato Morabito, Nadia Zucal, et al.
Hematological Oncology|February 10, 2026
Longitudinal Monitoring of Measurable Residual Disease in Chronic Lymphocytic Leukemia Patients Treated With Venetoclax: Results of a Prospective Multicenter Real-Life StudyLucia Farina, Alessandro Noto, Antonella Aiello, et al.
American Journal of Hematology|January 12, 2008
A multicenter retrospective clinical study of CD5/CD10-negative chronic B cell leukemiasMaria Goldaniga, Andrea Ferrario, Sergio Cortelazzo, et al.
Cancer|December 20, 2011
Fludarabine, cyclophosphamide, and rituximab in patients with advanced, untreated, indolent B-cell nonfollicular lymphomas: phase 2 study of the Italian Lymphoma FoundationAndrea Ferrario, Alessandro Pulsoni, Barbara Olivero, et al.
Pageof 7

Showing results (41-50 of 62) with videos related to

Sort By:
Pageof 7
Critical Care (London, England)|January 8, 2026
Longitudinal trajectories of functional outcome following aneurysmal subarachnoid hemorrhage: a retrospective studyIgnazio de Trizio, Andrea Ferrario, Stefan Yu Bögli, et al.
Journal of Biomedical Informatics|January 31, 2023
An interpretable machine learning approach to multimodal stress detection in a simulated office environmentMara Naegelin, Raphael P Weibel, Jasmine I Kerr, et al.
Psychoneuroendocrinology|September 22, 2020
The effects of acute work stress and appraisal on psychobiological stress responses in a group office environmentJasmine I Kerr, Mara Naegelin, Raphael P Weibel, et al.
Iscience|December 25, 2025
Beyond locomotion: How specialized motor patterns enable a vertebrate to struggle free from captureSaeed Farjami, Andrey Palyanov, Hong-Yan Zhang, et al.
Annals of Hematology|September 18, 2010
Phase II fludarabine and cyclophosphamide for the treatment of indolent B cell non-follicular lymphomas: final results of the LL02 trial of the Gruppo Italiano per lo Studio dei Linfomi (GISL)Andrea Ferrario, Francesco Merli, Stefano Luminari, et al.
Leukemia & Lymphoma|December 3, 2016
A new acute myeloid leukemia case with STAT5B-RARA gene fusion due to 17q21.2 interstitial deletionChiara Pessina, Claudia Basilico, Angelo Genoni, et al.
Hematological Oncology|February 28, 2009
CD26 expression in mature B-cell neoplasia: its possible role as a new prognostic marker in B-CLLLilla Cro, Fortunato Morabito, Nadia Zucal, et al.
Hematological Oncology|February 10, 2026
Longitudinal Monitoring of Measurable Residual Disease in Chronic Lymphocytic Leukemia Patients Treated With Venetoclax: Results of a Prospective Multicenter Real-Life StudyLucia Farina, Alessandro Noto, Antonella Aiello, et al.
American Journal of Hematology|January 12, 2008
A multicenter retrospective clinical study of CD5/CD10-negative chronic B cell leukemiasMaria Goldaniga, Andrea Ferrario, Sergio Cortelazzo, et al.
Cancer|December 20, 2011
Fludarabine, cyclophosphamide, and rituximab in patients with advanced, untreated, indolent B-cell nonfollicular lymphomas: phase 2 study of the Italian Lymphoma FoundationAndrea Ferrario, Alessandro Pulsoni, Barbara Olivero, et al.
Pageof 7